EGFR and neoplasm: Furthermore, numerous studies have demonstrated high concordance between ctDNA and tissue‐based EGFR mutation testing, including for T790M [11, 21, 26, 27]; however, discordance may occur due to tumor heterogeneity, variations in ctDNA shedding, or technical limitations.